scholarly journals Massive Secondary Cutaneous Meningioma with Extension to the Face

2020 ◽  
Vol 11 ◽  
pp. 209
Author(s):  
Turki Elarjani ◽  
Meshari Alhuthayl ◽  
Maher Hassounah
Keyword(s):  
Multidisciplinary Approach ◽  
Case Reports ◽  
World Health ◽  
Intracranial Meningioma ◽  
Bone Invasion ◽  
Code Status ◽  
Level Of Consciousness ◽  
The Face ◽  
Grade 3 ◽  
Health Organization

Background: Cutaneous meningioma is a very uncommon pathologic entity that can be divided into primary and secondary types. Secondary cutaneous meningioma arises from an intracranial meningioma through metastasis, seeding during surgery, or direct bone invasion. There are limited published case reports correlating the development of cutaneous meningioma to high-grade convexity meningioma. Case Description: A 63-year-old man underwent total resection of a right frontal convexity meningioma, World Health Organization Grade I in 2001. He presented in 2016 with a small frontal cutaneous mass over the craniotomy site. Computed tomography showed extracranial and intracranial components of the meningioma. The patient declined surgical intervention and lost to follow. One and half years later, he underwent resection of the growing ulcerating cutaneous component in an outside hospital. The pathological diagnosis was Grade 3 meningioma. Six months later, he presented to us with a massive cutaneous meningioma and large intracranial component. Surgical resection and multidisciplinary management were planned. The patient was very hesitant to have surgery but settled for receiving radiation. Seven months after radiation, he presented with a decreased level of consciousness and skin necrosis with maggot infestation. His code status was changed to “do not attempt resuscitation,” and he died 3 days later in December 2019. Conclusion: Large intracranial meningiomas with massive transosseous extension to the scalp pose a significant challenge to the treating team. Proper planning and a multidisciplinary approach are essential. However, prognosis remains generally poor.

scholarly journals The Utilization of Protective Face Masks among Polish Healthcare Workers during COVID-19 Pandemic: Do We Pass the Exam?

2021 ◽  
Vol 18 (2) ◽  
pp. 841
Author(s):  
Radomir Reszke ◽  
Łukasz Matusiak ◽  
Piotr K. Krajewski ◽  
Marta Szepietowska ◽  
Rafał Białynicki-Birula ◽  
...  
Keyword(s):  
Healthcare Workers ◽  
Medical Profession ◽  
Cross Sectional Study ◽  
Internet Survey ◽  
World Health ◽  
Cross Sectional ◽  
Protective Measures ◽  
Who Criteria ◽  
The Face ◽  
Health Organization

Relevant personal protective measures during the COVID-19 pandemic include face masks, possibly decreasing the risk of infection among the general population and healthcare workers (HCW) if utilized properly. The aim of the study was to assess whether different Polish HCW utilize face masks according to the 2020 World Health Organization guidance (WHO) criteria. This cross-sectional study included 1156 respondents who participated in an internet survey evaluating mask-related behaviors. All the WHO criteria were complied with by 1.4% of participants, regardless of medical profession, specialty or place of employment. HCW mostly adhered to criterion 1 (C1; strict covering of the face and mouth with the mask; 90.8%), C4 (washing/disinfecting the hands after touching/taking off the mask; 49%) and C3 (taking off the mask properly without touching the anterior surface; 43.4%), whereas C2 (avoidance of touching the mask with hands) was complied with least commonly (6.8%). HCW with mask-induced itch (31.6%) complied to C2 less often (odds ratio 0.53; p = 0.01). The study reveals that Polish HCW rarely adhere to all the 2020 WHO guidance criteria on the use of masks, whereas the adherence to particular criteria is variable and may be associated with the presence of skin-related conditions and other factors. Better compliance with the recommendations in the future is necessary to increase personal safety of HCW and prevent the transmission of SARS-CoV-2.

scholarly journals IoT and Deep Learning Based Approach for Rapid Screening and Face Mask Detection for Infection Spread Control of COVID-19

2021 ◽  
Vol 11 (8) ◽  
pp. 3495
Author(s):  
Shabir Hussain ◽  
Yang Yu ◽  
Muhammad Ayoub ◽  
Akmal Khan ◽  
Rukhshanda Rehman ◽  
...  
Keyword(s):  
Deep Learning ◽  
Low Cost ◽  
Face Mask ◽  
World Health ◽  
Rapid Screening ◽  
Screening System ◽  
Source Of Infection ◽  
The Face ◽  
Health Organization ◽  
Vaccine Distribution

The spread of COVID-19 has been taken on pandemic magnitudes and has already spread over 200 countries in a few months. In this time of emergency of COVID-19, especially when there is still a need to follow the precautions and developed vaccines are not available to all the developing countries in the first phase of vaccine distribution, the virus is spreading rapidly through direct and indirect contacts. The World Health Organization (WHO) provides the standard recommendations on preventing the spread of COVID-19 and the importance of face masks for protection from the virus. The excessive use of manual disinfection systems has also become a source of infection. That is why this research aims to design and develop a low-cost, rapid, scalable, and effective virus spread control and screening system to minimize the chances and risk of spread of COVID-19. We proposed an IoT-based Smart Screening and Disinfection Walkthrough Gate (SSDWG) for all public places entrance. The SSDWG is designed to do rapid screening, including temperature measuring using a contact-free sensor and storing the record of the suspected individual for further control and monitoring. Our proposed IoT-based screening system also implemented real-time deep learning models for face mask detection and classification. This module classified individuals who wear the face mask properly, improperly, and without a face mask using VGG-16, MobileNetV2, Inception v3, ResNet-50, and CNN using a transfer learning approach. We achieved the highest accuracy of 99.81% while using VGG-16 and the second highest accuracy of 99.6% using MobileNetV2 in the mask detection and classification module. We also implemented classification to classify the types of face masks worn by the individuals, either N-95 or surgical masks. We also compared the results of our proposed system with state-of-the-art methods, and we highly suggested that our system could be used to prevent the spread of local transmission and reduce the chances of human carriers of COVID-19.

scholarly journals Facial Recognition System for People with and without Face Mask in Times of the COVID-19 Pandemic

2021 ◽  
Vol 13 (12) ◽  
pp. 6900
Author(s):  
Jonathan S. Talahua ◽  
Jorge Buele ◽  
P. Calvopiña ◽  
José Varela-Aldás
Keyword(s):  
Facial Recognition ◽  
Face Mask ◽  
Recognition System ◽  
Classification Model ◽  
World Health ◽  
The Face ◽  
Recognition Systems ◽  
Facial Recognition System ◽  
Health Organization ◽  
Face Detector

In the face of the COVID-19 pandemic, the World Health Organization (WHO) declared the use of a face mask as a mandatory biosafety measure. This has caused problems in current facial recognition systems, motivating the development of this research. This manuscript describes the development of a system for recognizing people, even when they are using a face mask, from photographs. A classification model based on the MobileNetV2 architecture and the OpenCv’s face detector is used. Thus, using these stages, it can be identified where the face is and it can be determined whether or not it is wearing a face mask. The FaceNet model is used as a feature extractor and a feedforward multilayer perceptron to perform facial recognition. For training the facial recognition models, a set of observations made up of 13,359 images is generated; 52.9% images with a face mask and 47.1% images without a face mask. The experimental results show that there is an accuracy of 99.65% in determining whether a person is wearing a mask or not. An accuracy of 99.52% is achieved in the facial recognition of 10 people with masks, while for facial recognition without masks, an accuracy of 99.96% is obtained.

scholarly journals Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review

2021 ◽  
Vol 11 (3) ◽  
pp. 301
Author(s):  
Fatima Ghandour ◽  
Alessio Squassina ◽  
Racha Karaky ◽  
Mona Diab-Assaf ◽  
Paola Fadda ◽  
...  
Keyword(s):  
Brain Tumors ◽  
Psychiatric Symptoms ◽  
Case Reports ◽  
Neurological Symptoms ◽  
World Health ◽  
Exclusion Criteria ◽  
Comprehensive Description ◽  
Brain Tumor Diagnosis ◽  
Health Organization ◽  
Symptoms And Signs

Brain tumors can present with various psychiatric symptoms, with or without neurological symptoms, an aspect that complicates the clinical picture. However, no systematic description of symptoms that should prompt a neurological investigation has been provided. This review aims to summarize available case reports describing patients with brain tumors showing psychiatric symptoms before brain tumor diagnosis, in order to provide a comprehensive description of these symptoms as well as their potential relationship with delay in the diagnosis. A systematic literature review on case reports of brain tumors and psychiatric symptoms from 1970 to 2020 was conducted on PubMed, Ovid, Psych Info, and MEDLINE. Exclusion criteria comprised tumors not included in the World Health Organization (WHO) Classification 4th edition and cases in which psychiatric symptoms were absent or followed the diagnosis. A total of 165 case reports were analyzed. In a subset of patients with brain tumors, psychiatric symptoms can be the only manifestation or precede focal neurological signs by months or even years. The appearance of focal or generalized neurological symptoms after, rather than along with, psychiatric symptoms was associated with a significant delay in the diagnosis in adults. A timely assessment of psychiatric symptoms might help to improve early diagnosis of brain tumors.

scholarly journals Strengths and weaknesses of the Brazilian regulation on biosimilars: A critical view of the regulatory requirements for biosimilars in Brazil

2018 ◽  
Vol 10 (12) ◽  
pp. 253-259 ◽  
Author(s):  
Marcos Renato de Assis ◽  
Valdair Pinto
Keyword(s):  
Conflicts Of Interest ◽  
Expression System ◽  
World Health ◽  
Regulatory Requirements ◽  
Biological Products ◽  
Synthetic Drugs ◽  
Comparability Exercise ◽  
The Face ◽  
The Usa ◽  
Health Organization

Biological products or biopharmaceuticals are medicinal products derived from living systems and manufactured by modern biotechnological methods that differ widely from the traditional synthetic drugs. Monoclonal antibodies are the most rapidly growing type of biologic. They are much larger and more complex molecules with inherent diversity; therefore, different manufacturers cannot produce identical biological products, even with the same type of host expression system and equivalent technologies. Thus, legal follow-on biologics manufactured and marketed after patent expiration are usually referred to as biosimilars. Biosimilarity is based on a comparability exercise whereby unavoidable clinical differences are evaluated and must meet equivalence or non-inferiority criteria. Biosimilars need to comply with different regulatory requirements for market authorization in different sites. There are several other related issues that need to be defined by the national authorities, such as interchangeability, labeling and prescribing information. The Brazilian health surveillance agency follows the key principles established by the World Health Organization for the assessment of biosimilarity, although does not adopt the name ‘biosimilar’. However, the agency also made a compromise on a standalone application pathway that does not require the usual comparability exercise with the reference product, originating nonbiosimilar copies. Interchangeability and the use of nonproprietary names are not regulated, giving rise to pressures on physicians and conflicts of interest in the decision making on biosimilar use. The scope of this article is to present the Brazilian regulation on biosimilars, its strengths and weaknesses, and to discuss it in the face of regulations in the USA and Europe.

scholarly journals Mitigation/Adaptation and Health: Health Policymaking in the Global Response to Climate Change and Implications for other Upstream Determinants

2010 ◽  
Vol 38 (3) ◽  
pp. 629-639 ◽  
Author(s):  
Lindsay F. Wiley
Keyword(s):  
Climate Change ◽  
International Health ◽  
Environmental Research ◽  
World Health ◽  
Environmental Concerns ◽  
The Face ◽  
Development Goals ◽  
United Nations System ◽  
Health Organization ◽  
Development Objectives

In coming decades, enhanced global health governance will be crucial to achieving international health and development objectives in the face of a number of challenges; this article focuses on one of them. Climate change, which is now widely recognized as the defining challenge of the 21st century, will make the work of ensuring the conditions in which people can be healthy more difficult in a myriad of ways. Scientists from both the health and climate communities have been highlighting the significant interaction between climate and health for decades and have made significant strides in integrating health and environmental research. Those of us in the law and policy community have been a bit slow to catch up, and have only just begun to call for better integration of our responses to health and environmental concerns. Environmental health specialists at the World Health Organization have recently pointed to a mandate for better integration of health and environmental concerns within the United Nations system. The Millennium Development Goals interweave health, environmental, and development concerns.

scholarly journals A comparative analysis of world health systems and Covid-19

2021 ◽  
Vol 38 (2) ◽  
pp. 115-120
Author(s):  
Ayşe İKİNCİ KELEŞ ◽  
Gökhan KELEŞ
Keyword(s):  
Health Systems ◽  
Social Life ◽  
Meta Analysis ◽  
Good Health ◽  
The United States ◽  
World Health ◽  
The Face ◽  
The Usa ◽  
Health Organization ◽  
Second Wave

Coronavirus disease 2019 (COVID-19), which causes severe airway problems, first emerged in the Chinese city of Wuhan. The virus led to a pandemic that affected the entire world. COVID-19 affects not only health, but also economic and social life. The emergence of this pandemic has led to health systems across the world being questioned. The aim of this study was to assess the adequacy of world health systems in the face of this pandemic. Twelve countries were selected and analyzed in the study. The choice of these countries was determined by the number of COVID-19 cases and deaths. Information concerning health systems and COVID-19 was obtained from Organization for Economic Co-operation and Development 2018, World Health Organization 2020 and Deep Knowledge Group data and was subjected to statistical analysis. According to the analysis, the country with the highest investment in health expenditures is the United States (10586 US dollars/capita), and Germany stands out as the best in health services. Another finding is the first and second wave of COVID-19 was identified as the USA with the highest case and death rate (First wave cases 1.942.363 and deaths 110.514; second wave cases at 7.419.230 and deaths 2.09.450). As a result of the meta-analysis, it is revealed that only socio-economic power is not enough, countries with good health systems are more successful in the pandemic. In addition, the analysis once again reveal how important health systems are in the face of such a pandemic.

scholarly journals COVID-19 in the International Year of Plant Health

2022 ◽  
Vol 39 (4) ◽  
Author(s):  
José Jorge Gutiérrez-Samperio
Keyword(s):  
Life Forms ◽  
Plant Health ◽  
World Health ◽  
Human Beings ◽  
Pests And Diseases ◽  
The Bible ◽  
United Nations General ◽  
The World ◽  
The Face ◽  
Health Organization

<p>Pests, in their broad sense, have played an important part in the history of humankind. We could say that humans, crops and pests have walked together through life. Codices, glyphs, paintings and countless ancient documents, including the Bible and the Koran, bear witness to this. Humanity has been attacked by its own diseases, but also by those that limit them from obtaining food and deteriorate the environment. COVID-19, which is now troubling us and was declared a pandemic by the World Health Organization in March of 2020, became a part of the list of experiences we have suffered in the past, with pests or epidemics that caused millions of deaths by diseases or famines. It is paradoxical that this health contingency occurs when the United Nations General Assembly, on December 20th, 2018, in its resolution A/RES/73/252 decides to declare 2020 the International Year of Plant Health in order to “highlight the importance of plant health to improve food security, protect the environment and biodiversity and boost economic development” according to the pronouncement by the FAO. For the first time, in an era with great technological and scientific breakthroughs, humanity was aware of its vulnerability against the inevitable evolution of life forms in the face of dilemmas global impact caused by human beings. Thus, the pest or parasite makes its own declaration of existential preeminence through SARS-CoV-2 to remind us that the health of humans or plants is the essence of life and its continuity. But perhaps absolute health is not enough. It is necessary to find a balance in a world overwhelmed by giving so much in return for almost nothing to everyone living on it. If the sensor of our anthropocentric intervention of the world is climate change, then biological chaos is a masterpiece. The reemergence of pests and diseases considered eradicated, or those of zoonotic origin that had never accompanied our existence is a surreal dystopia that we will never be able to deny again.</p>

scholarly journals Adverse reactions to docetaxel: an active survey

2015 ◽  
Vol 51 (3) ◽  
pp. 551-559
Author(s):  
Leandro Cabral Pereira ◽  
Thaísa Amorim Nogueira ◽  
Leandro Augusto de Oliveira Barbosa ◽  
Sabrina Calil-Elias ◽  
Selma Rodrigues de Castilho
Keyword(s):  
Breast Cancer ◽  
Adverse Reactions ◽  
Breast Cancer Mortality ◽  
World Health ◽  
Healthcare Team ◽  
The Third ◽  
Naranjo Algorithm ◽  
Significant Difference ◽  
Grade 3 ◽  
Health Organization

The rates of breast cancer mortality remain high in Brazil. Docetaxel is a semi-synthetic taxane used to treat various tumors, particularly tumors of the breast, lung and prostate. In this study ADR that occurred in 45 docetaxel users with breast cancer were surveyed. They were identified by type, causality (Naranjo algorithm and World Health Organization categories) and, if considered probable or defined, rated for severity according to SOBRAFO proposal (2007). A total of 325 ADR were observed: 165 in the first, 137 in the second and 23 in the third cycle. Fifty seven ADR were immediate and the others, late. Fatigue and exhaustion for more than five days, classified as Grade 3 by SOBRAFO (2007), were reported as the primary late RAM. There was no significant difference in the occurrence of immediate and late ADR between cycles (p=1 and p=0.3577, respectively). The presence of a pharmacist gave the patients a better understanding of the occurrence of RAM, especially those that occur outside the hospital, between chemotherapy cycles and are often not reported to the healthcare team, creating institutional demands and reaching the goal to track, observe and correlate the RAM for each user.

scholarly journals The Stellenbosch Consensus on Legal National Responses to Public Health Risks

2020 ◽  
pp. 1-68
Author(s):  
Roojin Habibi ◽  
Steven J. Hoffman ◽  
Gian Luca Burci ◽  
Thana Cristina de Campos ◽  
Danwood Chirwa ◽  
...  
Keyword(s):  
Public Health ◽  
Global Health ◽  
International Health ◽  
World Health ◽  
Vienna Convention ◽  
Health Security ◽  
Public Health Emergencies ◽  
The Face ◽  
Health Organization ◽  
Health Regulations

Abstract The International Health Regulations (ihr), of which the World Health Organization is custodian, govern how countries collectively promote global health security, including prevention, detection, and response to global health emergencies such as the ongoing covid-19 pandemic. Countries are permitted to exercise their sovereignty in taking additional health measures to respond to such emergencies if these measures adhere to Article 43 of this legally binding instrument. Overbroad measures taken during recent public health emergencies of international concern, however, reveal that the provision remains inadequately understood. A shared understanding of the measures legally permitted by Article 43 is a necessary step in ensuring the fulfillment of obligations, and fostering global solidarity and resilience in the face of future pandemics. In this consensus statement, public international law scholars specializing in global health consider the legal meaning of Article 43 using the interpretive framework of the Vienna Convention on the Law of Treaties.

Sign in / Sign up

Export Citation Format

Share Document